ManciniA., ToddL.Inconsistencies in ISPD peritonitis recommendations: 2016 update on prevention and treatment and the ISPD catheter-related infection recommendations: 2017 update.Perit Dial Int2018; 38: 309–10.
FishR., NipahR., JonesC., FinneyH., FanS.L.Intraperitoneal vancomycin concentrations during peritoneal dialysis-associated peritonitis: correlation with serum levels.Perit Dial Int2012; 32: 332–8.
5.
BlundenM., ZeitlinD., AshmanN., FanS.L.Single UK centre experience on the treatment of PD peritonitis—antibiotic levels and outcomes.Nephrol Dial Transplant2007; 22: 1714–9.
6.
van GelderM.K., van Eck van der SluijsA., van MaarseveenE.M., Klein KlouwenbergP.M.C., AbrahamsA.C.Response letter to the “ISPD peritonitis recommendations: 2016 update on prevention and treatment.”Perit Dial Int2017; 37: 584–5.
7.
AnwarN., MerchantM., WereT., ToothA., UttleyL., GokalR.A prospective, randomized study of the comparative safety and efficacy of intraperitoneal imipenem versus vancomycin and netilmicin in the treatment of peritonitis on CAPD.Perit Dial Int1995; 15: 167–71.